Methodology for isolation, identification and characterization of microvesicles in peripheral blood

Muthuvel Jayachandran, Virginia M Miller, John A. Heit, Whyte G. Owen

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Rationale: Analyses of circulating cell membrane-derived microvesicles (MV) have come under scrutiny as potential diagnostic and prognostic biomarkers of disease. However, methods to isolate, label and quantify MV have been neither systematized nor validated. Objective: To determine how pre-analytical, analytical and post-analytical factors affect plasma MV counts, markers for cell of origin and expression of procoagulant surface phosphatidylserine. Methods and results: Peripheral venous blood samples were collected from healthy volunteers and patients with cardiovascular disease and/or diabetes. Effects of blood sample collection, anticoagulant and sample processing to platelet free plasma (PFP), and MV isolation, staining and storage (freeze-thaw) and cytometer design were evaluated with replicate samples from these populations. The key finding is that use of citrate or EDTA anticoagulants decreases or eliminates microvesicles from plasma by inducing adhesion of the microvesicles to platelets or other formed elements. Protease inhibitor anticoagulants, including heparin, preserve MV counts. A centrifugation protocol was developed in which recovery of isolated MV was high with resolution down to the equivalent light scatter of 0.2 μm latex beads. Each procedure was systematically evaluated for its impact on the MV counts and characteristics. Conclusion: This study provides a systematic methodology for MV isolation, identification and quantification, essential for development of MV as diagnostic and prognostic biomarkers of disease.

Original languageEnglish (US)
Pages (from-to)207-214
Number of pages8
JournalJournal of Immunological Methods
Volume375
Issue number1-2
DOIs
StatePublished - Jan 31 2012

Fingerprint

Anticoagulants
Blood Platelets
Biomarkers
Phosphatidylserines
Protease Inhibitors
Centrifugation
Microspheres
Edetic Acid
Citric Acid
Heparin
Healthy Volunteers
Cardiovascular Diseases
Cell Count
Cell Membrane
Staining and Labeling
Light
Population

Keywords

  • Anticoagulants
  • Flow cytometry
  • Microparticle
  • Phosphatidylserine
  • Pre-analytical and analytical variables

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Methodology for isolation, identification and characterization of microvesicles in peripheral blood. / Jayachandran, Muthuvel; Miller, Virginia M; Heit, John A.; Owen, Whyte G.

In: Journal of Immunological Methods, Vol. 375, No. 1-2, 31.01.2012, p. 207-214.

Research output: Contribution to journalArticle

Jayachandran, Muthuvel ; Miller, Virginia M ; Heit, John A. ; Owen, Whyte G. / Methodology for isolation, identification and characterization of microvesicles in peripheral blood. In: Journal of Immunological Methods. 2012 ; Vol. 375, No. 1-2. pp. 207-214.
@article{53fc6710b7194d2eb65c95f8d4dda888,
title = "Methodology for isolation, identification and characterization of microvesicles in peripheral blood",
abstract = "Rationale: Analyses of circulating cell membrane-derived microvesicles (MV) have come under scrutiny as potential diagnostic and prognostic biomarkers of disease. However, methods to isolate, label and quantify MV have been neither systematized nor validated. Objective: To determine how pre-analytical, analytical and post-analytical factors affect plasma MV counts, markers for cell of origin and expression of procoagulant surface phosphatidylserine. Methods and results: Peripheral venous blood samples were collected from healthy volunteers and patients with cardiovascular disease and/or diabetes. Effects of blood sample collection, anticoagulant and sample processing to platelet free plasma (PFP), and MV isolation, staining and storage (freeze-thaw) and cytometer design were evaluated with replicate samples from these populations. The key finding is that use of citrate or EDTA anticoagulants decreases or eliminates microvesicles from plasma by inducing adhesion of the microvesicles to platelets or other formed elements. Protease inhibitor anticoagulants, including heparin, preserve MV counts. A centrifugation protocol was developed in which recovery of isolated MV was high with resolution down to the equivalent light scatter of 0.2 μm latex beads. Each procedure was systematically evaluated for its impact on the MV counts and characteristics. Conclusion: This study provides a systematic methodology for MV isolation, identification and quantification, essential for development of MV as diagnostic and prognostic biomarkers of disease.",
keywords = "Anticoagulants, Flow cytometry, Microparticle, Phosphatidylserine, Pre-analytical and analytical variables",
author = "Muthuvel Jayachandran and Miller, {Virginia M} and Heit, {John A.} and Owen, {Whyte G.}",
year = "2012",
month = "1",
day = "31",
doi = "10.1016/j.jim.2011.10.012",
language = "English (US)",
volume = "375",
pages = "207--214",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Methodology for isolation, identification and characterization of microvesicles in peripheral blood

AU - Jayachandran, Muthuvel

AU - Miller, Virginia M

AU - Heit, John A.

AU - Owen, Whyte G.

PY - 2012/1/31

Y1 - 2012/1/31

N2 - Rationale: Analyses of circulating cell membrane-derived microvesicles (MV) have come under scrutiny as potential diagnostic and prognostic biomarkers of disease. However, methods to isolate, label and quantify MV have been neither systematized nor validated. Objective: To determine how pre-analytical, analytical and post-analytical factors affect plasma MV counts, markers for cell of origin and expression of procoagulant surface phosphatidylserine. Methods and results: Peripheral venous blood samples were collected from healthy volunteers and patients with cardiovascular disease and/or diabetes. Effects of blood sample collection, anticoagulant and sample processing to platelet free plasma (PFP), and MV isolation, staining and storage (freeze-thaw) and cytometer design were evaluated with replicate samples from these populations. The key finding is that use of citrate or EDTA anticoagulants decreases or eliminates microvesicles from plasma by inducing adhesion of the microvesicles to platelets or other formed elements. Protease inhibitor anticoagulants, including heparin, preserve MV counts. A centrifugation protocol was developed in which recovery of isolated MV was high with resolution down to the equivalent light scatter of 0.2 μm latex beads. Each procedure was systematically evaluated for its impact on the MV counts and characteristics. Conclusion: This study provides a systematic methodology for MV isolation, identification and quantification, essential for development of MV as diagnostic and prognostic biomarkers of disease.

AB - Rationale: Analyses of circulating cell membrane-derived microvesicles (MV) have come under scrutiny as potential diagnostic and prognostic biomarkers of disease. However, methods to isolate, label and quantify MV have been neither systematized nor validated. Objective: To determine how pre-analytical, analytical and post-analytical factors affect plasma MV counts, markers for cell of origin and expression of procoagulant surface phosphatidylserine. Methods and results: Peripheral venous blood samples were collected from healthy volunteers and patients with cardiovascular disease and/or diabetes. Effects of blood sample collection, anticoagulant and sample processing to platelet free plasma (PFP), and MV isolation, staining and storage (freeze-thaw) and cytometer design were evaluated with replicate samples from these populations. The key finding is that use of citrate or EDTA anticoagulants decreases or eliminates microvesicles from plasma by inducing adhesion of the microvesicles to platelets or other formed elements. Protease inhibitor anticoagulants, including heparin, preserve MV counts. A centrifugation protocol was developed in which recovery of isolated MV was high with resolution down to the equivalent light scatter of 0.2 μm latex beads. Each procedure was systematically evaluated for its impact on the MV counts and characteristics. Conclusion: This study provides a systematic methodology for MV isolation, identification and quantification, essential for development of MV as diagnostic and prognostic biomarkers of disease.

KW - Anticoagulants

KW - Flow cytometry

KW - Microparticle

KW - Phosphatidylserine

KW - Pre-analytical and analytical variables

UR - http://www.scopus.com/inward/record.url?scp=84855354256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855354256&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2011.10.012

DO - 10.1016/j.jim.2011.10.012

M3 - Article

C2 - 22075275

AN - SCOPUS:84855354256

VL - 375

SP - 207

EP - 214

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -